BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21415362)

  • 1. A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers.
    Wang T; Rohan TE; Gunter MJ; Xue X; Wactawski-Wende J; Rajpathak SN; Cushman M; Strickler HD; Kaplan RC; Wassertheil-Smoller S; Scherer PE; Ho GY
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):971-7. PubMed ID: 21415362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
    Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis.
    Dossus L; Lukanova A; Rinaldi S; Allen N; Cust AE; Becker S; Tjonneland A; Hansen L; Overvad K; Chabbert-Buffet N; Mesrine S; Clavel-Chapelon F; Teucher B; Chang-Claude J; Boeing H; Drogan D; Trichopoulou A; Benetou V; Bamia C; Palli D; Agnoli C; Galasso R; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; van Duijnhoven FJ; Peeters PH; Onland-Moret NC; Redondo ML; Travier N; Sanchez MJ; Altzibar JM; Chirlaque MD; Barricarte A; Lundin E; Khaw KT; Wareham N; Fedirko V; Romieu I; Romaguera D; Norat T; Riboli E; Kaaks R
    Am J Epidemiol; 2013 Apr; 177(8):787-99. PubMed ID: 23492765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
    Gunter MJ; Hoover DR; Yu H; Wassertheil-Smoller S; Rohan TE; Manson JE; Li J; Ho GY; Xue X; Anderson GL; Kaplan RC; Harris TG; Howard BV; Wylie-Rosett J; Burk RD; Strickler HD
    J Natl Cancer Inst; 2009 Jan; 101(1):48-60. PubMed ID: 19116382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women.
    Brinton LA; Trabert B; Anderson GL; Falk RT; Felix AS; Fuhrman BJ; Gass ML; Kuller LH; Pfeiffer RM; Rohan TE; Strickler HD; Xu X; Wentzensen N
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1081-9. PubMed ID: 27197275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-control study of inflammatory markers and the risk of endometrial cancer.
    Friedenreich CM; Langley AR; Speidel TP; Lau DC; Courneya KS; Csizmadi I; Magliocco AM; Yasui Y; Cook LS
    Eur J Cancer Prev; 2013 Jul; 22(4):374-9. PubMed ID: 23702681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study.
    Dossus L; Rinaldi S; Becker S; Lukanova A; Tjonneland A; Olsen A; Stegger J; Overvad K; Chabbert-Buffet N; Jimenez-Corona A; Clavel-Chapelon F; Rohrmann S; Teucher B; Boeing H; Schütze M; Trichopoulou A; Benetou V; Lagiou P; Palli D; Berrino F; Panico S; Tumino R; Sacerdote C; Redondo ML; Travier N; Sanchez MJ; Altzibar JM; Chirlaque MD; Ardanaz E; Bueno-de-Mesquita HB; van Duijnhoven FJ; Onland-Moret NC; Peeters PH; Hallmans G; Lundin E; Khaw KT; Wareham N; Allen N; Key TJ; Slimani N; Hainaut P; Romaguera D; Norat T; Riboli E; Kaaks R
    Endocr Relat Cancer; 2010 Dec; 17(4):1007-19. PubMed ID: 20843938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: Quantification of the mediating effects of leptin, C-reactive protein, fasting insulin, and estradiol.
    Dashti SG; Simpson JA; Viallon V; Karahalios A; Moreno-Betancur M; Brasky T; Pan K; Rohan TE; Shadyab AH; Thomson CA; Wild RA; Wassertheil-Smoller S; Ho GYF; Strickler HD; English DR; Gunter MJ
    Cancer Med; 2022 Feb; 11(4):1145-1159. PubMed ID: 35048536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
    Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
    Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipokines linking obesity with colorectal cancer risk in postmenopausal women.
    Ho GY; Wang T; Gunter MJ; Strickler HD; Cushman M; Kaplan RC; Wassertheil-Smoller S; Xue X; Rajpathak SN; Chlebowski RT; Vitolins MZ; Scherer PE; Rohan TE
    Cancer Res; 2012 Jun; 72(12):3029-37. PubMed ID: 22511581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
    Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
    JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer.
    Gunter MJ; Hoover DR; Yu H; Wassertheil-Smoller S; Manson JE; Li J; Harris TG; Rohan TE; Xue X; Ho GY; Einstein MH; Kaplan RC; Burk RD; Wylie-Rosett J; Pollak MN; Anderson G; Howard BV; Strickler HD
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):921-9. PubMed ID: 18398032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control study of endogenous steroid hormones and endometrial cancer.
    Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
    J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum glucose and insulin and risk of cancers of the breast, endometrium, and ovary in postmenopausal women.
    Kabat GC; Kim MY; Lane DS; Zaslavsky O; Ho GYF; Luo J; Nicholson WK; Chlebowski RT; Barrington WE; Vitolins MZ; Lin X; Liu S; Rohan TE
    Eur J Cancer Prev; 2018 May; 27(3):261-268. PubMed ID: 29438162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
    Lukanova A; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Arslan AA; Rinaldi S; Muti P; Lenner P; Koenig KL; Biessy C; Krogh V; Riboli E; Shore RE; Stattin P; Berrino F; Hallmans G; Toniolo P; Kaaks R
    Int J Cancer; 2004 Jan; 108(2):262-8. PubMed ID: 14639613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Endogenous Pregnenolone, Progesterone, and Related Metabolites with Risk of Endometrial and Ovarian Cancers in Postmenopausal Women: The B
    Trabert B; Geczik AM; Bauer DC; Buist DSM; Cauley JA; Falk RT; Gierach GL; Hue TF; Lacey JV; LaCroix AZ; Michels KA; Tice JA; Xu X; Brinton LA; Dallal CM
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2030-2037. PubMed ID: 34465588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort.
    Agnoli C; Grioni S; Pala V; Allione A; Matullo G; Gaetano CD; Tagliabue G; Sieri S; Krogh V
    Sci Rep; 2017 Oct; 7(1):12708. PubMed ID: 28983080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
    Trabert B; Eldridge RC; Pfeiffer RM; Shiels MS; Kemp TJ; Guillemette C; Hartge P; Sherman ME; Brinton LA; Black A; Chaturvedi AK; Hildesheim A; Berndt SI; Safaeian M; Pinto L; Wentzensen N
    Int J Cancer; 2017 Feb; 140(3):600-610. PubMed ID: 27770434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.
    Cust AE; Kaaks R; Friedenreich C; Bonnet F; Laville M; Lukanova A; Rinaldi S; Dossus L; Slimani N; Lundin E; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Mesrine S; Joulin V; Linseisen J; Rohrmann S; Pischon T; Boeing H; Trichopoulos D; Trichopoulou A; Benetou V; Palli D; Berrino F; Tumino R; Sacerdote C; Mattiello A; Quirós JR; Mendez MA; Sánchez MJ; Larrañaga N; Tormo MJ; Ardanaz E; Bueno-de-Mesquita HB; Peeters PH; van Gils CH; Khaw KT; Bingham S; Allen N; Key T; Jenab M; Riboli E
    J Clin Endocrinol Metab; 2007 Jan; 92(1):255-63. PubMed ID: 17062769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.